Genomic impact of cigarette smoke, with application to three smoking-related diseases

References

• Adenuga D, Rahman I. (2010). Protein kinase CK2-mediated phosphorylation of HDAC2 regulates co-repressor formation, deacetylase activity and acetylation of HDAC2 by cigarette smoke and aldehydes. Arch Biochem Biophys 498:62–73.
   PubMed Web of Science ®Google Scholar
• Adenuga D, Yao H, March TH, Seagrave J, Rahman I. (2009). Histone deacetylase 2 is phosphorylated, ubiquitinated, and degraded by cigarette smoke. Am J Respir Cell Mol Biol 40:464–473.
   PubMed Web of Science ®Google Scholar
• Andreassi MG, Botto N. (2003). DNA damage as a new emerging risk factor in atherosclerosis. Trends Cardiovasc Med 13:270–275.
   PubMed Web of Science ®Google Scholar
• Anisowicz A, Huang H, Braunschweiger KI, Liu Z, Giese H, Wang H, Mamaev S, Olejnik J, Massion PP, Del Mastro RG. (2008). A high-throughput and sensitive method to measure global DNA methylation: application in lung cancer. BMC Cancer 8:222.
   PubMedGoogle Scholar
• Anna L, Holmila R, Kovács K, Gyorffy E, Gyori Z, Segesdi J, Minárovits J, Soltész I, Kostic S, Csekeo A, Husgafvel-Pursiainen K, Schoket B. (2009). Relationship between TP53 tumour suppressor gene mutations and smoking-related bulky DNA adducts in a lung cancer study population from Hungary. Mutagenesis 24:475–480.
   PubMed Web of Science ®Google Scholar
• Barlow S, Renwick AG, Kleiner J, Bridges JW, Busk L, Dybing E, Edler L, Eisenbrand G, Fink-Gremmels J, Knaap A, Kroes R, Liem D, Müller DJ, Page S, Rolland V, Schlatter J, Tritscher A, Tueting W, Würtzen G. (2006). Risk assessment of substances that are both genotoxic and carcinogenic report of an International Conference organized by EFSA and WHO with support of ILSI Europe. Food Chem Toxicol 44:1636–1650.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Adcock IM, Ito K. (2005). Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J 25:552–563.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. (2006). Reduced histone deacetylase in COPD: clinical implications. Chest 129:151–155.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. (2009). Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 6:693–696.
   PubMedGoogle Scholar
• Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. (2007). High-resolution profiling of histone methylations in the human genome. Cell 129:823–837.
   PubMed Web of Science ®Google Scholar
• Baryshnikova E, Destro A, Infante MV, Cavuto S, Cariboni U, Alloisio M, Ceresoli GL, Lutman R, Brambilla G, Chiesa G, Ravasi G, Roncalli M. (2008). Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results from a large screening program. Clin Cancer Res 14:1913–1919.
   PubMed Web of Science ®Google Scholar
• Beane J, Vick J, Schembri F, Anderlind C, Gower A, Campbell J, Luo L, Zhang XH, Xiao J, Alekseyev YO, Wang S, Levy S, Massion PP, Lenburg M, Spira A. (2011). Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq. Cancer Prev Res (Phila) 4:803–817.
   PubMed Web of Science ®Google Scholar
• Begum S, Brait M, Dasgupta S, Ostrow KL, Zahurak M, Carvalho AL, Califano JA, Goodman SN, Westra WH, Hoque MO, Sidransky D. (2011). An epigenetic marker panel for detection of lung cancer using cell-free serum DNA. Clin Cancer Res 17:4494–4503.
   PubMed Web of Science ®Google Scholar
• Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, Gabrielson E, Baylin SB, Herman JG. (1998). Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA 95:11891–11896.
   PubMed Web of Science ®Google Scholar
• Belinsky SA. (2005). Silencing of genes by promoter hypermethylation: key event in rodent and human lung cancer. Carcinogenesis 26:1481–1487.
   PubMed Web of Science ®Google Scholar
• Belinsky SA, Klinge DM, Dekker JD, Smith MW, Bocklage TJ, Gilliland FD, Crowell RE, Karp DD, Stidley CA, Picchi MA. (2005). Gene promoter methylation in plasma and sputum increases with lung cancer risk. Clin Cancer Res 11:6505–6511.
   PubMed Web of Science ®Google Scholar
• Belinsky SA, Liechty KC, Gentry FD, Wolf HJ, Rogers J, Vu K, Haney J, Kennedy TC, Hirsch FR, Miller Y, Franklin WA, Herman JG, Baylin SB, Bunn PA, Byers T. (2006). Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res 66:3338–3344.
   PubMed Web of Science ®Google Scholar
• Bhutani M, Pathak AK, Fan YH, Liu DD, Lee JJ, Tang H, Kurie JM, Morice RC, Kim ES, Hong WK, Mao L. (2008). Oral epithelium as a surrogate tissue for assessing smoking-induced molecular alterations in the lungs. Cancer Prev Res (Phila) 1:39–44.
   PubMed Web of Science ®Google Scholar
• Bock C, Tomazou EM, Brinkman AB, Müller F, Simmer F, Gu H, Jäger N, Gnirke A, Stunnenberg HG, Meissner A. (2010). Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat Biotechnol 28:1106–1114.
   PubMed Web of Science ®Google Scholar
• Broët P, Dalmasso C, Tan EH, Alifano M, Zhang S, Wu J, Lee MH, Régnard JF, Lim D, Koong HN, Agasthian T, Miller LD, Lim E, Camilleri-Broët S, Tan P. (2011). Genomic profiles specific to patient ethnicity in lung adenocarcinoma. Clin Cancer Res 17:3542–3550.
   PubMed Web of Science ®Google Scholar
• Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W. (1995). Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet 11:210–212.
   PubMed Web of Science ®Google Scholar
• Chen ZH, Kim HP, Sciurba FC, Lee SJ, Feghali-Bostwick C, Stolz DB, Dhir R, Landreneau RJ, Schuchert MJ, Yousem SA, Nakahira K, Pilewski JM, Lee JS, Zhang Y, Ryter SW, Choi AM. (2008). Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS ONE 3:e3316.
   PubMed Web of Science ®Google Scholar
• Chi P, Allis CD, Wang GG. (2010). Covalent histone modifications–miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer 10:457–469.
   PubMed Web of Science ®Google Scholar
• Chung JH, Lee HJ, Kim BH, Cho NY, Kang GH. (2011). DNA methylation profile during multistage progression of pulmonary adenocarcinomas. Virchows Arch 459:201–211.
   PubMed Web of Science ®Google Scholar
• Coggins CR. (2010). A further review of inhalation studies with cigarette smoke and lung cancer in experimental animals, including transgenic mice. Inhal Toxicol 22:974–983.
   PubMed Web of Science ®Google Scholar
• Dacic S, Shuai Y, Yousem S, Ohori P, Nikiforova M. (2010). Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomas. Mod Pathol 23:159–168.
   PubMed Web of Science ®Google Scholar
• Damiani LA, Yingling CM, Leng S, Romo PE, Nakamura J, Belinsky SA. (2008). Carcinogen-induced gene promoter hypermethylation is mediated by DNMT1 and causal for transformation of immortalized bronchial epithelial cells. Cancer Res 68:9005–9014.
   PubMed Web of Science ®Google Scholar
• DeMarini DM, Gudi R, Szkudlinska A, Rao M, Recio L, Kehl M, Kirby PE, Polzin G, Richter PA. (2008). Genotoxicity of 10 cigarette smoke condensates in four test systems: comparisons between assays and condensates. Mutat Res 650:15–29.
   PubMed Web of Science ®Google Scholar
• Denissenko MF, Chen JX, Tang MS, Pfeifer GP. (1997). Cytosine methylation determines hot spots of DNA damage in the human P53 gene. Proc Natl Acad Sci USA 94:3893–3898.
   PubMed Web of Science ®Google Scholar
• Denissenko MF, Pao A, Tang M, Pfeifer GP. (1996). Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 274:430–432.
   PubMed Web of Science ®Google Scholar
• Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, Sougnez C, Greulich H, Muzny DM, Morgan MB, Fulton L, Fulton RS, Zhang Q, Wendl MC, Lawrence MS, Larson DE, Chen K, Dooling DJ, Sabo A, Hawes AC, Shen H, Jhangiani SN, Lewis LR, Hall O, Zhu Y, Mathew T, Ren Y, Yao J, Scherer SE, Clerc K, Metcalf GA, Ng B, Milosavljevic A, Gonzalez-Garay ML, Osborne JR, Meyer R, Shi X, Tang Y, Koboldt DC, Lin L, Abbott R, Miner TL, Pohl C, Fewell G, Haipek C, Schmidt H, Dunford-Shore BH, Kraja A, Crosby SD, Sawyer CS, Vickery T, Sander S, Robinson J, Winckler W, Baldwin J, Chirieac LR, Dutt A, Fennell T, Hanna M, Johnson BE, Onofrio RC, Thomas RK, Tonon G, Weir BA, Zhao X, Ziaugra L, Zody MC, Giordano T, Orringer MB, Roth JA, Spitz MR, Wistuba II, Ozenberger B, Good PJ, Chang AC, Beer DG, Watson MA, Ladanyi M, Broderick S, Yoshizawa A, Travis WD, Pao W, Province MA, Weinstock GM, Varmus HE, Gabriel SB, Lander ES, Gibbs RA, Meyerson M, Wilson RK. (2008). Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455:1069–1075.
   PubMed Web of Science ®Google Scholar
• Dolinoy DC, Jirtle RL. (2008). Environmental epigenomics in human health and disease. Environ Mol Mutagen 49:4–8.
   PubMed Web of Science ®Google Scholar
• Dunn BK. (2003). Hypomethylation: one side of a larger picture. Ann N Y Acad Sci 983:28–42.
   PubMed Web of Science ®Google Scholar
• Edwards SW, Preston RJ. (2008). Systems biology and mode of action based risk assessment. Toxicol Sci 106:312–318.
   PubMed Web of Science ®Google Scholar
• Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R. (2008). Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15:504–514.
   PubMed Web of Science ®Google Scholar
• Esteller M. (2007). Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet 16 Spec No 1:R50–R59.
   PubMed Web of Science ®Google Scholar
• Feng Q, Hawes SE, Stern JE, Wiens L, Lu H, Dong ZM, Jordan CD, Kiviat NB, Vesselle H. (2008). DNA methylation in tumor and matched normal tissues from non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 17:645–654.
   PubMed Web of Science ®Google Scholar
• Fish JE, Yan MS, Matouk CC, St Bernard R, Ho JJ, Ho JJ Jr, Gavryushova A, Srivastava D, Marsden PA. (2010). Hypoxic repression of endothelial nitric-oxide synthase transcription is coupled with eviction of promoter histones. J Biol Chem 285:810–826.
   PubMed Web of Science ®Google Scholar
• Franklin WA, Gazdar AF, Haney J, Wistuba II, La Rosa FG, Kennedy T, Ritchey DM, Miller YE. (1997). Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J Clin Invest 100:2133–2137.
   PubMed Web of Science ®Google Scholar
• Garinis GA, Gorgoulis VG, Mariatos G, Zacharatos P, Kotsinas A, Liloglou T, Foukas P, Kanavaros P, Kastrinakis NG, Vassilakopoulos T, Vogiatzi T, Field JK, Kittas C. (2001). Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs). J Pathol 193:55–65.
   PubMed Web of Science ®Google Scholar
• Gautschi O, Ratschiller D, Gugger M, Betticher DC, Heighway J. (2007). Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation. Lung Cancer 55:1–14.
   PubMed Web of Science ®Google Scholar
• Gazdar AF, Minna JD. (2009). Multifocal lung cancers–clonality vs field cancerization and does it matter? J Natl Cancer Inst 101:541–543.
   PubMedGoogle Scholar
• Gebel S, Gerstmayer B, Bosio A, Haussmann HJ, Van Miert E, Müller T. (2004). Gene expression profiling in respiratory tissues from rats exposed to mainstream cigarette smoke. Carcinogenesis 25:169–178.
   PubMed Web of Science ®Google Scholar
• Gebel S, Gerstmayer B, Kuhl P, Borlak J, Meurrens K, Müller T. (2006). The kinetics of transcriptomic changes induced by cigarette smoke in rat lungs reveals a specific program of defense, inflammation, and circadian clock gene expression. Toxicol Sci 93:422–431.
   PubMed Web of Science ®Google Scholar
• Guo X, Verkler TL, Chen Y, Richter PA, Polzin GM, Moore MM, Mei N. (2011). Mutagenicity of 11 cigarette smoke condensates in two versions of the mouse lymphoma assay. Mutagenesis 26:273–281.
   PubMed Web of Science ®Google Scholar
• Haberland M, Johnson A, Mokalled MH, Montgomery RL, Olson EN. (2009). Genetic dissection of histone deacetylase requirement in tumor cells. Proc Natl Acad Sci USA 106:7751–7755.
   PubMed Web of Science ®Google Scholar
• Hammons G, Lyn-Cook B. (2011). Epigenetics in tobacco smoke exposure. Curr Top Toxicol 7:63–77.
   Google Scholar
• Hang B. (2010). Formation and repair of tobacco carcinogen-derived bulky DNA adducts. J Nucleic Acids 2010:709521.
   PubMedGoogle Scholar
• Harris RA, Wang T, Coarfa C, Nagarajan RP, Hong C, Downey SL, Johnson BE, Fouse SD, Delaney A, Zhao Y, Olshen A, Ballinger T, Zhou X, Forsberg KJ, Gu J, Echipare L, O’Geen H, Lister R, Pelizzola M, Xi Y, Epstein CB, Bernstein BE, Hawkins RD, Ren B, Chung WY, Gu H, Bock C, Gnirke A, Zhang MQ, Haussler D, Ecker JR, Li W, Farnham PJ, Waterland RA, Meissner A, Marra MA, Hirst M, Milosavljevic A, Costello JF. (2010). Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat Biotechnol 28:1097–1105.
   PubMed Web of Science ®Google Scholar
• Hartung T. (2009). A toxicology for the 21st century–mapping the road ahead. Toxicol Sci 109:18–23.
   PubMed Web of Science ®Google Scholar
• He X, Chang S, Zhang J, Zhao Q, Xiang H, Kusonmano K, Yang L, Sun ZS, Yang H, Wang J. (2008). MethyCancer: the database of human DNA methylation and cancer. Nucleic Acids Res 36:D836–D841.
   PubMed Web of Science ®Google Scholar
• Herbst RS, Heymach JV, Lippman SM. (2008). Lung cancer. N Engl J Med 359:1367–1380.
   PubMed Web of Science ®Google Scholar
• Hoeng J, Deehan R, Pratt D, Martin F, Sewer A, Thomson TM, Drubin DA, Waters CA, de Graaf D, Peitsch MC. (2012). A network-based approach to quantifying the impact of biologically active substances. Drug Discov Today 17:413–418.
   PubMed Web of Science ®Google Scholar
• Hou L, Zhang X, Wang D, Baccarelli A. (2012). Environmental chemical exposures and human epigenetics. Int J Epidemiol 41:79–105.
   PubMed Web of Science ®Google Scholar
• Huang YT, Lin X, Liu Y, Chirieac LR, McGovern R, Wain J, Heist R, Skaug V, Zienolddiny S, Haugen A, Su L, Fox EA, Wong KK, Christiani DC. (2011). Cigarette smoking increases copy number alterations in nonsmall-cell lung cancer. Proc Natl Acad Sci USA 108:16345–16350.
   PubMed Web of Science ®Google Scholar
• Huss M. (2010). Introduction into the analysis of high-throughput-sequencing based epigenome data. Brief Bioinformatics 11:512–523.
   PubMed Web of Science ®Google Scholar
• Ito K, Barnes PJ. (2009). COPD as a disease of accelerated lung aging. Chest 135:173–180.
   PubMed Web of Science ®Google Scholar
• Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM, Hogg JC, Barnes PJ. (2005). Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 352:1967–1976.
   PubMed Web of Science ®Google Scholar
• Jarmalaite S, Kannio A, Anttila S, Lazutka JR, Husgafvel-Pursiainen K. (2003). Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer. Int J Cancer 106:913–918.
   PubMed Web of Science ®Google Scholar
• Johnson MD, Schilz J, Djordjevic MV, Rice JR, Shields PG. (2009). Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco. Cancer Epidemiol Biomarkers Prev 18:3263–3304.
   PubMed Web of Science ®Google Scholar
• Kerr KM, Galler JS, Hagen JA, Laird PW, Laird-Offringa IA. (2007). The role of DNA methylation in the development and progression of lung adenocarcinoma. Dis Markers 23:5–30.
   PubMed Web of Science ®Google Scholar
• Kim H, Kwon YM, Kim JS, Lee H, Park JH, Shim YM, Han J, Park J, Kim DH. (2004). Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer. J Clin Oncol 22:2363–2370.
   PubMed Web of Science ®Google Scholar
• Kim M, Long TI, Arakawa K, Wang R, Yu MC, Laird PW. (2010). DNA methylation as a biomarker for cardiovascular disease risk. PLoS ONE 5:e9692
   PubMed Web of Science ®Google Scholar
• Lamy A, Sesboüé R, Bourguignon J, Dautréaux B, Métayer J, Frébourg T, Thiberville L. (2002). Aberrant methylation of the CDKN2a/p16INK4a gene promoter region in preinvasive bronchial lesions: a prospective study in high-risk patients without invasive cancer. Int J Cancer 100:189–193.
   PubMed Web of Science ®Google Scholar
• Lantuéjoul S, Salameire D, Salon C, Brambilla E. (2009). Pulmonary preneoplasia–sequential molecular carcinogenetic events. Histopathology 54:43–54.
   PubMed Web of Science ®Google Scholar
• Launay JM, Del Pino M, Chironi G, Callebert J, Peoc’h K, Mégnien JL, Mallet J, Simon A, Rendu F. (2009). Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation. PLoS ONE 4:e7959.
   PubMed Web of Science ®Google Scholar
• Lee YJ, Shim HS, Kang YA, Hong SJ, Kim HK, Kim H, Kim SK, Choi SH, Kim JH, Cho BC. (2010). Dose effect of cigarette smoking on frequency and spectrum of epidermal growth factor receptor gene mutations in Korean patients with non-small cell lung cancer. J Cancer Res Clin Oncol 136:1937–1944.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhu J, Tian G, Li N, Li Q, Ye M, Zheng H, Yu J, Wu H, Sun J, Zhang H, Chen Q, Luo R, Chen M, He Y, Jin X, Zhang Q, Yu C, Zhou G, Sun J, Huang Y, Zheng H, Cao H, Zhou X, Guo S, Hu X, Li X, Kristiansen K, Bolund L, Xu J, Wang W, Yang H, Wang J, Li R, Beck S, Wang J, Zhang X. (2010). The DNA methylome of human peripheral blood mononuclear cells PLoS.Biol 8:e1000533.
   PubMed Web of Science ®Google Scholar
• Licchesi JD, Westra WH, Hooker CM, Herman JG. (2008). Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung. Clin Cancer Res 14:2570–2578.
   PubMed Web of Science ®Google Scholar
• Lin RK, Hsieh YS, Lin P, Hsu HS, Chen CY, Tang YA, Lee CF, Wang YC. (2010). The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients. J Clin Invest 120:521–532.
   PubMed Web of Science ®Google Scholar
• Liu F, Killian JK, Yang M, Walker RL, Hong JA, Zhang M, Davis S, Zhang Y, Hussain M, Xi S, Rao M, Meltzer PA, Schrump DS. (2010). Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene 29:3650–3664.
   PubMed Web of Science ®Google Scholar
• Liu H, Zhou Y, Boggs SE, Belinsky SA, Liu J. (2007). Cigarette smoke induces demethylation of prometastatic oncogene synuclein-gamma in lung cancer cells by downregulation of DNMT3B. Oncogene 26:5900–5910.
   PubMed Web of Science ®Google Scholar
• Lund G, Andersson L, Lauria M, Lindholm M, Fraga MF, Villar-Garea A, Ballestar E, Esteller M, Zaina S. (2004). DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol Chem 279:29147–29154.
   PubMed Web of Science ®Google Scholar
• Mao L, Lee JS, Kurie JM, Fan YH, Lippman SM, Lee JJ, Ro JY, Broxson A, Yu R, Morice RC, Kemp BL, Khuri FR, Walsh GL, Hittelman WN, Hong WK. (1997). Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 89:857–862.
   PubMed Web of Science ®Google Scholar
• Martin F, Thomson TM, Sewer A, Drubin DA, Mathis C, Weisensee D, Pratt D, Hoeng J, Peitsch MC. (2012). Assessment of network perturbation amplitude by applying high-throughput data to causal biological networks. BMC Syst Biol 6:54.
   PubMed Web of Science ®Google Scholar
• Marwick JA, Kirkham PA, Stevenson CS, Danahay H, Giddings J, Butler K, Donaldson K, Macnee W, Rahman I. (2004). Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs. Am J Respir Cell Mol Biol 31:633–642.
   PubMed Web of Science ®Google Scholar
• Mass MJ, Wang L. (1997). Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat Res 386:263–277.
   PubMed Web of Science ®Google Scholar
• Mendrick DL. (2008). Toxicogenomics and classic toxicology: how to improve prediction and mechanistic understanding of human toxicity. Methods Mol Biol 460:1–22.
   PubMedGoogle Scholar
• Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D. (1995). 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1:686–692.
   PubMed Web of Science ®Google Scholar
• Monick MM, Beach SR, Plume J, Sears R, Gerrard M, Brody GH, Philibert RA. (2012). Coordinated changes in AHRR methylation in lymphoblasts and pulmonary macrophages from smokers. Am J Med Genet B Neuropsychiatr Genet 159B:141–151.
   PubMed Web of Science ®Google Scholar
• Nelson HH, Wiencke JK, Gunn L, Wain JC, Christiani DC, Kelsey KT. (1998). Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos. Cancer Res 58:1804–1807.
   PubMed Web of Science ®Google Scholar
• Niedringhaus TP, Milanova D, Kerby MB, Snyder MP, Barron AE. (2011). Landscape of next-generation sequencing technologies. Anal Chem 83:4327–4341.
   PubMed Web of Science ®Google Scholar
• Nowell PC. (1976). The clonal evolution of tumor cell populations. Science 194:23–28.
   PubMed Web of Science ®Google Scholar
• OECD. (1997). Guideline for the Testing OF Chemicals. In Vitro Mammalian Cell Gene Mutation Test. Available at: http://www.oecd-ilibrary.org/docserver/download/fulltext/9747601e.pdf?expires=1332790058&id=id&accname=freeContent&checksum=01D755899A5653A11A1D2211DD51662D
   Google Scholar
• Ongenaert M. (2010). Epigenetic databases and computational methodologies in the analysis of epigenetic datasets. Adv. Genet. 71:259–295.
   PubMed Web of Science ®Google Scholar
• Ostrow KL, Hoque MO, Loyo M, Brait M, Greenberg A, Siegfried JM, Grandis JR, Gaither Davis A, Bigbee WL, Rom W, Sidransky D. (2010). Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCR. Clin Cancer Res 16:3463–3472.
   PubMed Web of Science ®Google Scholar
• Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, Belinsky SA. (2000). Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60:5954–5958.
   PubMed Web of Science ®Google Scholar
• Peters AH, O’Carroll D, Scherthan H, Mechtler K, Sauer S, Schöfer C, Weipoltshammer K, Pagani M, Lachner M, Kohlmaier A, Opravil S, Doyle M, Sibilia M, Jenuwein T. (2001). Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107:323–337.
   PubMed Web of Science ®Google Scholar
• Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. (2002). Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21:7435–7451.
   PubMed Web of Science ®Google Scholar
• Pfeifer GP, Hainaut P. (2011). Next-generation sequencing: emerging lessons on the origins of human cancer. Curr Opin Oncol 23:62–68.
   PubMed Web of Science ®Google Scholar
• Phillips JM, Goodman JI. (2009). Inhalation of cigarette smoke induces regions of altered DNA methylation (RAMs) in SENCAR mouse lung. Toxicology 260:7–15.
   PubMed Web of Science ®Google Scholar
• Pleasance ED, Stephens PJ, O’Meara S, McBride DJ, Meynert A, Jones D, Lin ML, Beare D, Lau KW, Greenman C, Varela I, Nik-Zainal S, Davies HR, Ordoñez GR, Mudie LJ, Latimer C, Edkins S, Stebbings L, Chen L, Jia M, Leroy C, Marshall J, Menzies A, Butler A, Teague JW, Mangion J, Sun YA, McLaughlin SF, Peckham HE, Tsung EF, Costa GL, Lee CC, Minna JD, Gazdar A, Birney E, Rhodes MD, McKernan KJ, Stratton MR, Futreal PA, Campbell PJ. (2010). A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463:184–190.
   PubMed Web of Science ®Google Scholar
• Pulling LC, Vuillemenot BR, Hutt JA, Devereux TR, Belinsky SA. (2004). Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens. Cancer Res 64:3844–3848.
   PubMed Web of Science ®Google Scholar
• Qiu W, Baccarelli A, Carey VJ, Boutaoui N, Bacherman H, Klanderman B, Rennard S, Agusti A, Anderson W, Lomas DA, DeMeo DL. (2012). Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function. Am J Respir Crit Care Med 185:373–381.
   PubMed Web of Science ®Google Scholar
• Rahman I. (2002). Oxidative stress, transcription factors and chromatin remodelling in lung inflammation. Biochem Pharmacol 64:935–942.
   PubMed Web of Science ®Google Scholar
• Rahman I, Gilmour PS, Jimenez LA, MacNee W. (2002). Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. Mol Cell Biochem 234-235:239–248.
   PubMed Web of Science ®Google Scholar
• Rajendrasozhan S, Yang SR, Kinnula VL, Rahman I. (2008). SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177:861–870.
   PubMed Web of Science ®Google Scholar
• Rauch T, Li H, Wu X, Pfeifer GP. (2006). MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells. Cancer Res 66:7939–7947
   PubMed Web of Science ®Google Scholar
• Rivera C, Rivera S, Loriot Y, Vozenin MC, Deutsch E. (2011). Lung cancer stem cell: new insights on experimental models and preclinical data. J Oncol 2011:549181.
   PubMedGoogle Scholar
• Rusin MR, Okamoto A, Chorazy M, Czyzewski K, Harasim J, Spillare EA, Hagiwara K, Hussain SP, Xiong Y, Demetrick DJ, Harris CC. (1996). Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers. Int J Cancer 65:734–739.
   PubMed Web of Science ®Google Scholar
• Russo AL, Thiagalingam A, Pan H, Califano J, Cheng KH, Ponte JF, Chinnappan D, Nemani P, Sidransky D, Thiagalingam S. (2005). Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer. Clin Cancer Res 11:2466–2470.
   PubMed Web of Science ®Google Scholar
• Ryberg D, Kure E, Lystad S, Skaug V, Stangeland L, Mercy I, Børresen AL, Haugen A. (1994). p53 mutations in lung tumors: relationship to putative susceptibility markers for cancer. Cancer Res 54:1551–1555.
   PubMed Web of Science ®Google Scholar
• Sandoval J, Esteller M. (2012). Cancer epigenomics: beyond genomics. Curr Opin Genet Dev 22:50–55.
   PubMed Web of Science ®Google Scholar
• Schär P, Fritsch O. (2011). DNA repair and the control of DNA methylation. Prog Drug Res 67:51–68.
   PubMedGoogle Scholar
• Schleef RR. (2006) Animal Models for Three Cigarette-Smoke-Induced Diseases.Boca Raton: CRC Press, Taylor & Francis.
   Google Scholar
• Selamat SA, Galler JS, Joshi AD, Fyfe MN, Campan M, Siegmund KD, Kerr KM, Laird-Offringa IA. (2011). DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma. PLoS ONE 6:e21443.
   PubMed Web of Science ®Google Scholar
• Shames DS, Girard L, Gao B, Sato M, Lewis CM, Shivapurkar N, Jiang A, Perou CM, Kim YH, Pollack JR, Fong KM, Lam CL, Wong M, Shyr Y, Nanda R, Olopade OI, Gerald W, Euhus DM, Shay JW, Gazdar AF, Minna JD. (2006). A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS Med 3:e486.
   PubMed Web of Science ®Google Scholar
• Shan B, Yao TP, Nguyen HT, Zhuo Y, Levy DR, Klingsberg RC, Tao H, Palmer ML, Holder KN, Lasky JA. (2008). Requirement of HDAC6 for transforming growth factor-beta1-induced epithelial-mesenchymal transition. J Biol Chem 283:21065–21073.
   PubMed Web of Science ®Google Scholar
• Sharma P, Kumar J, Garg G, Kumar A, Patowary A, Karthikeyan G, Ramakrishnan L, Brahmachari V, Sengupta S. (2008). Detection of altered global DNA methylation in coronary artery disease patients. DNA Cell Biol 27:357–365.
   PubMed Web of Science ®Google Scholar
• Spira A, Schembri F, Beane J, Shah V, Liu G, Brody JS. (2004). Impact of cigarette smoke on the normal airway transcriptome. Chest 125:115S.
   Web of Science ®Google Scholar
• Steiling K, Ryan J, Brody JS, Spira A. (2008). The field of tissue injury in the lung and airway. Cancer Prev Res (Phila) 1:396–403.
   PubMed Web of Science ®Google Scholar
• Stein RA. (2012). Epigenetics and environmental exposures. J Epidemiol Community Health 66:8–13.
   PubMed Web of Science ®Google Scholar
• Subramanian J, Govindan R. (2010). Lung cancer in ‘Never-smokers’: a unique entity. Oncology (Williston Park, NY) 24:29–35.
   PubMed Web of Science ®Google Scholar
• Sun S, Schiller JH, Gazdar AF. (2007). Lung cancer in never smokers–a different disease. Nat Rev Cancer 7:778–790.
   PubMed Web of Science ®Google Scholar
• Sundar IK, Mullapudi N, Yao H, Spivack SD, Rahman I. (2011). Lung cancer and its association with chronic obstructive pulmonary disease: update on nexus of epigenetics. Curr Opin Pulm Med 17:279–285.
   PubMed Web of Science ®Google Scholar
• Szulakowski P, Crowther AJ, Jiménez LA, Donaldson K, Mayer R, Leonard TB, MacNee W, Drost EM. (2006). The effect of smoking on the transcriptional regulation of lung inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 174:41–50.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services. (2010). How tobacco smoke causes disease: The biology and behavioral basis for smoking-attributable disease: A report of the Surgeon General., Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health: Atlanta, GA.
   Google Scholar
• U.S. Department of Health and Human Services. (2011). Harmful and potentially harmful constituents in tobacco products and tobacco smoke; request for comments., Food and Drug Administration, Federal Register, Vol. 76. Washington, DC: Docket No. FDA-2011-N-0271.
   Google Scholar
• Van Eeden S, Leipsic J, Paul Man SF, Sin DD. (2012). The relationship between lung inflammation and cardiovascular disease. Am J Respir Crit Care Med 186:11–16.
   PubMed Web of Science ®Google Scholar
• Wierda RJ, Geutskens SB, Jukema JW, Quax PH, van den Elsen PJ. (2010). Epigenetics in atherosclerosis and inflammation. J Cell Mol Med 14:1225–1240.
   PubMed Web of Science ®Google Scholar
• Wistuba II, Lam S, Behrens C, Virmani AK, Fong KM, LeRiche J, Samet JM, Srivastava S, Minna JD, Gazdar AF. (1997). Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst 89:1366–1373.
   PubMed Web of Science ®Google Scholar
• Wynder EL. (1980). Some concepts of the less harmful cigarette, in A safe cigarette? Banbury Report 3. Cold Spring Harbor Laboratory.
   Google Scholar
• Yanagawa N, Tamura G, Oizumi H, Endoh M, Sadahiro M, Motoyama T. (2011). Inverse correlation between EGFR mutation and FHIT, RASSF1A and RUNX3 methylation in lung adenocarcinoma: relation with smoking status. Anticancer Res 31:1211–1214.
   PubMed Web of Science ®Google Scholar
• Yang IA, Relan V, Wright CM, Davidson MR, Sriram KB, Savarimuthu Francis SM, Clarke BE, Duhig EE, Bowman RV, Fong KM. (2011). Common pathogenic mechanisms and pathways in the development of COPD and lung cancer. Expert Opin Ther Targets 15:439–456.
   PubMed Web of Science ®Google Scholar
• Yang SR, Valvo S, Yao H, Kode A, Rajendrasozhan S, Edirisinghe I, Caito S, Adenuga D, Henry R, Fromm G, Maggirwar S, Li JD, Bulger M, Rahman I. (2008). IKK alpha causes chromatin modification on pro-inflammatory genes by cigarette smoke in mouse lung. Am J Respir Cell Mol Biol 38:689–698.
   PubMed Web of Science ®Google Scholar
• Zabarovsky ER, Lerman MI, Minna JD. (2002). Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 21:6915–6935.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Tavoosidana G, Sjölinder M, Göndör A, Mariano P, Wang S, Kanduri C, Lezcano M, Sandhu KS, Singh U, Pant V, Tiwari V, Kurukuti S, Ohlsson R. (2006). Circular chromosome conformation capture (4C) uncovers extensive networks of epigenetically regulated intra- and interchromosomal interactions. Nat Genet 38:1341–1347.
   PubMed Web of Science ®Google Scholar
• Zhou B, Margariti A, Zeng L, Xu Q. (2011). Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis. Cardiovasc Res 90:413–420.
   PubMed Web of Science ®Google Scholar
• Zochbauer-Muller S, Minna JD, Gazdar AF. (2002). Aberrant DNA methylation in lung cancer: biological and clinical implications. Oncologist 7:451–457.
   PubMed Web of Science ®Google Scholar
• Zöchbauer-Müller S, Lam S, Toyooka S, Virmani AK, Toyooka KO, Seidl S, Minna JD, Gazdar AF. (2003). Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokers. Int J Cancer 107:612–616.
   PubMed Web of Science ®Google Scholar